Indian Pharma Caps And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 3.00 M
- Company Age 52 Year, 1 Day
- Last Filing with ROC 31 Mar 2018
- Revenue Growth %
- Profit Growth 9.54%
- Ebitda
- Net Worth -0.27%
- Total Assets -7.17%
About Indian Pharma Caps And Chemicals
Indian Pharma Caps And Chemicals Private Limited (IPCACPL) was founded in India on 31 January 1973 and has a glorious history of 52 years .Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Poonam Bhagat and Rajani Bhagat serve as directors at the Company.
Company Details
-
LocationMumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1973PTC016280
-
Company No.
016280
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jan 1973
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Indian Pharma Caps And Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Bhagat
|
Director | 05-May-2013 | Current |
|
Rajani Bhagat
|
Director | 31-Jan-1973 | Current |
Financial Performance of Indian Pharma Caps And Chemicals.
Indian Pharma Caps And Chemicals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 9.54% increase in profit. The company's net worth dipped by a decrease of 0.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indian Pharma Caps And Chemicals?
In 2017, Indian Pharma Caps And Chemicals had a promoter holding of 14.08% and a public holding of 85.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bhagat Trading Company Private LimitedPoonam Bhagat and Rajani Bhagat are mutual person
-
Punu Trading & Investment Company Private Limited
Poonam Bhagat and Rajani Bhagat are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indian Pharma Caps And Chemicals?
Unlock and access historical data on people associated with Indian Pharma Caps And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indian Pharma Caps And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian Pharma Caps And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
